• Info
  • Insider Ownership

Insider Trading & Ownership of Andrew R. Allen

Location
Boulder, CO
Summary
The estimated net worth of Andrew R. Allen is at least $1,873,541 dollars as of 08 Aug 2025. Andrew R. Allen is the PRESIDENT AND CEO, Director of Gritstone bio, Inc. and owns shares of Gritstone bio, Inc. stock worth about $1.82M. Andrew R. Allen is the Director of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $51.7K.
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Andrew R. Allen files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Andrew R. Allen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GRTS Gritstone bio, Inc. PRESIDENT AND CEO, Director $1,821,838 24 Jun 2024
EPZM Epizyme, Inc. Director $51,703 11 Jun 2021
ADAP, ADAPY Adaptimmune Therapeutics PLC Director 01 Jul 2024
CGEM Cullinan Therapeutics, Inc. Director 07 Aug 2025
SRRA Sierra Oncology, Inc. Director, 10%+ Owner 01 Jul 2022
TCRR TCR2 THERAPEUTICS INC. Director 01 Jun 2023

Insider Transactions Reported by Andrew R. Allen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.